Organization · Venture Capital
Tachyon Ventures
Tachyon Ventures is a Los Angeles-based venture capital firm that invests in early-stage life sciences companies, focusing on biotech and bioengineering. They support scientific teams with protected intellectual property and promising early research data.
Overview
What Tachyon Ventures does
What Tachyon Ventures is
Tachyon Ventures is a Los Angeles-based venture capital firm that invests in early-stage life sciences companies, focusing on biotech and bioengineering. They support scientific teams with protected intellectual property and promising early research data.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Tachyon Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Tachyon Ventures as a funder
Investment thesis
Tachyon Ventures focuses on early-stage investments in medicine, biotech, and bioengineering, emphasizing scientific risk-arbitrage to identify promising innovations. They prioritize companies with protected intellectual property and strong scientific teams.
Focus narrative
Tachyon Ventures specializes in early-stage investments, particularly in transformative technologies within the biotech sector. Their investment thesis emphasizes scientific risk-arbitrage, allowing them to identify and invest in promising scientific innovations early in their development. They prioritize companies with protected intellectual property and those led by teams recognized for their world-class research.
Value beyond capital
Tachyon Ventures adds value to its portfolio companies by leveraging a network of scientists from leading research institutions, providing access to expertise and resources that can accelerate development. Their focus on companies with protected intellectual property ensures that they back innovations with strong competitive advantages.
Terms and economics
- Typical check
- $500,000–$3,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- United StatesNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 13
- Recorded notable exits
- Mammoth Biosciences
Portfolio context
Mammoth Biosciences: A CRISPR-based platform for developing tests in healthcare, agriculture, manufacturing, and forensics. Enclear Therapies: Focuses on systems to halt neurodegenerative diseases by removing toxic proteins. Totient: A high-throughput drug discovery platform for monoclonal antibodies. DTx Pharma: Develops a siRNA delivery platform for selective therapeutic targeting. Scipher Medicine: Creates tests to predict responses to major drugs and new targeted therapies. Forkhead: Works on treating insulin-dependent diabetes by exploiting gut cell plasticity. Quthero: Enables epithelial restoration through collective cell migration. Peptilogics: Develops novel peptide anti-infective therapeutics. EpiBone: Produces personalized bone grafts made from digitally designed stem cells. TARA: Focuses on engineered human cardiac tissues with advanced functional maturity.
Common questions
What to know about Tachyon Ventures
Upseed classifies Tachyon Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.